||

Connecting Communities, One Page at a Time.

advertisement
advertisement

KIET Deemed to be University hosts PHARMAMANTHAN–2026 on industry 5.0 in pharmaceutical sciences

KIET Deemed to be University hosts PHARMAMANTHAN–2026, spotlighting Industry 5.0 with AI-driven, human-centric and sustainable innovations in pharmaceutical sciences.

EPN Desk 28 April 2026 05:26

KIET Deemed to be University

KIET Deemed to be University successfully organized PHARMAMANTHAN–2026, a flagship academic and industry interface event, at its campus, on 27th April 2026. The event brought together eminent academicians, regulators, industry leaders, and budding pharmacy professionals. The event was centered on the theme “Human-centric, AI-driven, Sustainable Approach in Drug Discovery, Development and Regulation,” reflecting the evolving paradigm of Industry 5.0 in pharmaceutical sciences.

The inaugural ceremony was graced by distinguished dignitaries including Dr. Manoj Goel, Pro Vice Chancellor and Dr. Adesh Kumar Pandey, Director Academics, whose visionary leadership continues to foster academic excellence and industry integration at the institution along with Dr. Preeti Chitkara-Head PR and International Relations-KIET.

Advertisement

Dr. K. Nagarajan, Principal, KIET School of Pharmacy, welcomed the guests and participants, highlighting the importance of interdisciplinary learning and innovation-driven research in addressing global healthcare challenges. He emphasized the institution’s commitment to nurturing future-ready pharmacy professionals aligned with emerging technological advancements.

The event witnessed insightful addresses from renowned experts across regulatory, industrial, and research domains. Chief Guest- Dr. Vibhu Sahni, Chairman, Finance Committee, PCI, New Delhi, emphasized the role of regulatory frameworks in ensuring quality and patient safety. Chief Guest -Mr. Chetan Gupta, Senior Vice President – Corporate Affairs, Emcure Pharmaceuticals Limited, shared perspectives on industry expectations and corporate responsibility in a rapidly evolving pharmaceutical landscape.

Guest of Honour-Mr. A.K. Pradhan, Ex-Joint Drug Controller of India, provided valuable insights into drug regulatory mechanisms and policy evolution in India. Guest of Honour-Dr. Raghu Rangaswamy, CEO, Molecular Solutions Software Pvt. Ltd., highlighted the transformative role of digital technologies and AI in accelerating drug discovery and development.

Further enriching the discourse, Guest of Honour -Dr. Bhulan Kr. Singh, Manager, Medical Writing – Global Clinical Research Operations, Glenmark Pharmaceuticals Ltd., elaborated on the critical importance of scientific communication and clinical documentation in global research. Eminent Resource Speaker-Mr. Akhilesh Kr. Tewari, Assistant General Manager, Formulation and Development, Mankind Research Centre, Gurugram, shared industry-oriented perspectives on formulation challenges and innovations. Eminent Resource Speaker -Dr. Kailash Malik, Assistant Drugs Controller (India), CDSCO, DGHS, MoHFW, Government of India, discussed regulatory advancements and their impact on pharmaceutical practices.

The successful organization of PHARMAMANTHAN–2026 stands as a testament to the meticulous planning and dedicated efforts of the organizing team under the overall coordination of Dr. Praveen K. Dixit Asst.Head Dept. Skill Development Cell and Dr. Richa Goel-Associate Dean-IPR whose commitment ensured seamless execution of the event.

The event served as a dynamic platform for knowledge exchange, fostering collaboration between academia, industry, and regulatory bodies. More than 315 Students and 40 Faculty members actively engaged in discussions, gaining exposure to real-world challenges and opportunities in the pharmaceutical sector.

The event concluded with a strong message on the need for a human-centric and technology-driven approach in shaping the future of healthcare, reinforcing KIET’s vision of academic excellence, innovation, and societal impact.

Also Read


    advertisement